price jan
result sale miss increas
report disappoint result sale growth
expect higher cost invest busi acquisit
verili sale growth weaker expect compani
still achiev posit sale growth appear take market share
remain cautiou compani acquisit invest verili
transpar turnaround return prole articul
retain hold rate given limit tsr
report result weaker forecast revenu
vs dbe gross prot vs dbe underli
ebit vs dbe howev underli npat ahead
forecast due low tax expens manag also guid
higher expens ratio futur invest verili higher interest expens
previous forecast
reduc revenu growth rate america devic row
devic row mask accessori increas gross margin
assumpt assum invest made verili jv
increas sg expens ratio increas
interest expens forecast increas amortis expens
forecast chang led ep reduct reduct
valuat risk
revis tp deriv use dcf valuat methodolog
dcf use wacc coe d/ev upsid
risk includ higher expect devic mask sale due increas
fund reimburs lead stronger expect devic sale
upgrad telemonitor devic addit synergi saa acquisit
key downsid risk includ advers chang reimburs new competitor
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
reduc revenu growth rate america devic row devic
row mask accessori
increas gross margin assumpt
assum invest made verili jv
increas sg expens ratio
increas interest expens forecast
increas amortis expens forecast
chang led ep reduct reduct
report result weaker forecast revenu
vs dbe gross prot vs dbe underli
ebit vs dbe howev underli npat ahead
forecast due low tax expens manag also guid
higher expens ratio futur invest verili higher interest expens
previous forecast
highlight result includ
group revenu growth weakest last
quarter howev note still continu grow faster competitor
impli take market share
revenu vs pcp dbe devic
revenu growth vs came
lower dbe mask accessori revenu growth remain strong
vs line dbe
compani mask growth continu benet new mask launch
on-going resuppli contract
rest world segment row segment report revenu
cc growth vs pcp came dbe main reason
miss row devic experienc cc growth vs dbe
manag attribut neg row devic growth japan
franc longer see upgrad telemonitor devic
sale pull forward earlier period manag expect
devic sale japan franc remain low next quarter
recov normal industri growth rate row mask accessori cc
growth also dbe howev manag said
still geographi yet launch new mask
continu good tailwind futur growth
figur rest world revenu growth
brightre brightre report revenu vs pcp
slightli lower dbe high growth mainli attribut
consolid healthcarefirst matrixcar busi manag
said brightre core busi experienc mid high singl digit growth
quarter broadli consist growth achiev
manag attribut lower growth vs histor growth
consolid dme subsequ insourc servic
manag plan improv growth histor level howev
expect take quarter occur manag provid updat
guidanc recent acquisit say expect matrixcar ep
accret per quarter propel health expect ep
dilut per quarter manag previous guid propel health
ep dilut per quarter said increas fund cost caus
acquisit dilut
devic total global devic growth lower forecast
well pcp
mask accessori growth total global mask accessori growth
slighti forecast line
achiev
gross margin gross margin ahead dbe
margin improv due manufactur
ecienc favor product mix matrixcar acquisit
partial oset declin averag sell price exclud impact fair
valu adjust relat matrixcar purchas account defer revenu
gross margin came quarter manag guid
gross margin broadli consist gross margin
sg sg expens cc basi vs pcp
dbe sg percentag sale
slightli lower dbe manag guid guidanc
sg broadli around
 expens cc basi vs pcp
slighti dbe percentag sale
larg line dbe exclud eect acquisit
 expens decreas manag guid guidanc
 increas expens ratio caus addit
saa acquisit spend
sale januari
underli ebit underli ebit came vs dbe
pcp translat ebit margin vs dbe
pcp
net interest expens net interest expens came vs dbe
pcp increas vs pcp manag
guid net interest expens per quarter remaind
reect increas debt posit higher interest expens rate
invest verili jv compani invest verili jv
incur equiti account loss manag expect
expens per quarter expect continu invest beyond
assum anoth invest assum
return invest acknowledg treatment
verili invest overli conserv comfort approach
detail provid manag
tax tax lower dbe impli tax
rate vs dbe manag attribut low eectiv tax rate
benet employe share base payment manag guid
tax rate rang
net debt compani report net debt dec vs dbe
sep gear increas dec vs dbe
sep
cash-flow compani report opcf vs dbe
pcp ebitda cash convers ratio quarter vs
capital-expenditure compani report capital-expenditure vs dbe
pcp
dividend board declar dividend vs dbe
pcp
vs vs margin margin margin interest expens expens rate growth c/share c/share vs vs excl totaltot revenuerevenu cc excl revenu januari
valuat risk
target price prev base dcf
valuat use three-stag dcf model discount post-tax free cash ow
target price increas due increas earn forecast
wacc assum beta coe risk-fre rate
assum long-term govern bond rate standard market risk premium
target d/ev forecast explicit cash ow follow
horizon period cash ow growth fade long-term
termin valu growth rate set termin growth rate
slight premium nomin global estim reect long term
demand trend rmd osa product
increas fund reimburs lead higher expect
devic mask sale
expect devic sale caus upgrad
addit synergi saa acquisit
signic reduct product fund reimburs
new innov product releas competitor lead market
elev price pressur increas competit
model januari numbersaustralasiaaustraliahealth biotechnologyresmedreut nbloomberg usholdpric jan week cap profileresm global leader develop manufactur distribut market medic devic cloud-bas softwar applic diagnos treat managerespiratori disord price performanceresmedal ordinari rebas jan trendsebitda marginebit profitibilitysal growth lh roe debt/equ lh net interest cover year summarydb ep ep metricsprice/sal db report yield yield statement usdm flow cash raised/ bought inc/ dec investing/financ cash cash work sheet usdm cash plant sharehold compani metricssal growth ep growth ratio margin margin debt/equ interest cover analysisebit margin asset turnov financi cost ratio tax effect roa post tax financi leverag roe growth nta/shar average report growth compani data deutsch bank estim januari
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
